Emergent BioSolutions Inc. (0IGA.L)
USD 8.5
(-3.22%)
USD 8.5
(-3.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -206.3 Million | -34.1 Million | 321.1 Million | 536 Million | 188 Million | 41.8 Million |
| Net Income | -760.5 Million | -223.8 Million | 230.9 Million | 305.1 Million | 54.5 Million | 62.7 Million |
| Depreciation & Amortization | 129.1 Million | 143.3 Million | 123.8 Million | 114.5 Million | 110.7 Million | 62.2 Million |
| Deferred income taxes | -8.9 Million | -19 Million | 46.9 Million | -2.4 Million | -1.6 Million | 8.6 Million |
| Stock-based compensation | 23.1 Million | 45.1 Million | 42.4 Million | 51.8 Million | 26.7 Million | 23.2 Million |
| Change in working capital | -70.3 Million | 500 Thousand | -156.4 Million | 8.8 Million | -39.9 Million | -119.1 Million |
| Other non-cash items | 481.2 Million | 19.8 Million | 33.5 Million | 59 Million | 37.6 Million | 4.2 Million |
| Investing Cash Flow | 212.3 Million | -381.3 Million | -225 Million | -151 Million | -96.9 Million | -897.2 Million |
| Investments in PPE | -51.6 Million | -115.8 Million | -225 Million | -141 Million | -86.9 Million | -72.1 Million |
| Acquisitions | 270.2 Million | - | - | - | - | -827.7 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -6.3 Million | -265.5 Million | - | -10 Million | -10 Million | 2.6 Million |
| Financing Cash Flow | -535.7 Million | 481.2 Million | -141 Million | 69.5 Million | -35.9 Million | 788.7 Million |
| Debt repayment | -543.4 Million | -33.8 Million | -35.9 Million | -387.1 Million | -116.3 Million | -2.8 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -2.5 Million | -82.1 Million | -119.8 Million | -13.8 Million | -7.4 Million | -100 Thousand |
| Common Stock Issuance | 10.2 Million | 5 Million | 15.9 Million | 31.6 Million | 8.19 Million | 15.9 Million |
| Other Financing Activities | -2.5 Million | 597.1 Million | 14.7 Million | 456.6 Million | 80.4 Million | 791.6 Million |
| Accounts receivables | -21.6 Million | 114.7 Million | -48.2 Million | 49 Million | -8.2 Million | -94.2 Million |
| Accounts payables | 10.6 Million | -14 Million | -2.5 Million | 19.8 Million | 16.5 Million | -7 Million |
| Inventory | 600 Thousand | -51.9 Million | -44 Million | -83.2 Million | -16.7 Million | -1.9 Million |
| Other working capital | -59.9 Million | -48.3 Million | -61.7 Million | 23.2 Million | -31.5 Million | -16 Million |
| Cash at beginning of period | 642.6 Million | 576.3 Million | 621.5 Million | 168 Million | 112.4 Million | 179.3 Million |
| Cash at end of period | 111.7 Million | 642.6 Million | 576.3 Million | 621.5 Million | 168 Million | 112.4 Million |
| Capital Expenditure | -51.6 Million | -115.8 Million | -225 Million | -141 Million | -86.9 Million | -72.1 Million |
| Effect of forex changes on cash | -1.2 Million | 500 Thousand | -300 Thousand | -1 Million | 400 Thousand | -200 Thousand |
| Net cash flow / Change in cash | -530.9 Million | 66.3 Million | -45.2 Million | 453.5 Million | 55.6 Million | -66.9 Million |
| Free Cash Flow | -257.9 Million | -149.9 Million | 96.1 Million | 395 Million | 101.1 Million | -30.3 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -283.1 Million | 9 Million | -760.5 Million | -49.5 Million | -263.39 Million | -261.3 Million |
| Depreciation & Amortization | 29.4 Million | 28.8 Million | 129.1 Million | 30.5 Million | 29.1 Million | 32.9 Million |
| Deferred income taxes | -200 Thousand | -12.2 Million | -8.9 Million | -5.2 Million | 6.5 Million | -1.8 Million |
| Stock-based compensation | 5.5 Million | 5.9 Million | 23.1 Million | 4 Million | 4 Million | 8.3 Million |
| Change in working capital | 205.9 Million | -97.5 Million | -70.3 Million | 46.5 Million | 65.2 Million | -145.2 Million |
| Other non-cash items | 144.3 Million | 123.8 Million | 481.2 Million | 5.8 Million | 218.59 Million | 252.7 Million |
| Investing Cash Flow | -4.6 Million | -10.8 Million | 212.3 Million | -11.4 Million | -18.9 Million | 257.7 Million |
| Investments in PPE | -4.6 Million | -10.8 Million | -51.6 Million | -11.4 Million | -12.6 Million | -12.5 Million |
| Acquisitions | - | - | 270.2 Million | -270.2 Million | - | 270.2 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -6.3 Million | 270.2 Million | -6.3 Million | 270.2 Million |
| Financing Cash Flow | -50.9 Million | 40.7 Million | -535.7 Million | 4.7 Million | -43 Million | -486.9 Million |
| Debt repayment | -51.4 Million | -41.1 Million | -543.4 Million | -4.09 Million | -42.9 Million | -496.2 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -200 Thousand | -400 Thousand | -2.5 Million | -100 Thousand | -100 Thousand | -200 Thousand |
| Common Stock Issuance | 700 Thousand | - | 10.2 Million | 700 Thousand | - | 9.5 Million |
| Other Financing Activities | -200 Thousand | -400 Thousand | -2.5 Million | 8.09 Million | -100 Thousand | 9.3 Million |
| Accounts receivables | 20.4 Million | -50 Million | -21.6 Million | 36.9 Million | 72.1 Million | -132.4 Million |
| Accounts payables | 2.6 Million | -2.4 Million | 10.6 Million | -7.1 Million | 6.8 Million | -20.1 Million |
| Inventory | -13 Million | -4.5 Million | 600 Thousand | 25.6 Million | -1.2 Million | 5.8 Million |
| Other working capital | 195.9 Million | -40.6 Million | -59.9 Million | -8.9 Million | -12.5 Million | 1.5 Million |
| Cash at beginning of period | 79 Million | 111.7 Million | 642.6 Million | 87.8 Million | 88.6 Million | 430.2 Million |
| Cash at end of period | 71 Million | 79 Million | 111.7 Million | 111.7 Million | -1.9 Million | 88.6 Million |
| Capital Expenditure | -4.6 Million | -10.8 Million | -51.6 Million | -11.4 Million | -12.6 Million | -12.5 Million |
| Effect of forex changes on cash | - | - | -1.2 Million | -1.5 Million | 1.1 Million | -600 Thousand |
| Net cash flow / Change in cash | -8 Million | -32.7 Million | -530.9 Million | 23.9 Million | -90.5 Million | -341.6 Million |
| Free Cash Flow | 42.9 Million | -73.4 Million | -257.9 Million | 20.7 Million | 47.4 Million | -126.9 Million |
TXG
PLX
NBG6
WONDERLA
EMAMIREAL
4001